by Carl-Johan Skoeld | Apr 28, 2014 | General, Healthcare, SSCO Newsletters
This post was originally published in the September 2013 issue of our healthcare newsletter China Healthcare Deals+Strategies. Subscribe (email) to our newsletter to learn more about our perspectives and insights on China’s healthcare sector. Improving wound...
by Carl-Johan Skoeld | Apr 24, 2014 | China M&A, General, Healthcare, SSCO Newsletters
This post was originally published in February 2014 issue of our healthcare newsletter China Healthcare Deals+Strategies. Subscribe (email) to our newsletter to learn more about our perspectives and insights on China’s healthcare sector. Competitive impact of...
by Carl-Johan Skoeld | Mar 6, 2014 | China M&A, General, Healthcare, SSCO Newsletters
This post was originally published in February 2014 issue of our healthcare newsletter China Healthcare Deals+Strategies. Subscribe (email) to our newsletter to learn more about our perspectives and insights on China’s healthcare sector. M&A and...
by Carl-Johan Skoeld | Sep 12, 2013 | China M&A, China Outbound M&A, Healthcare, SSCO Newsletters
Outbound Deals Fosun Pharma move into highend medical devices by acquiring Alma Lasers In May 2013, Shanghai Fosun Pharmaceutical Group Co. Ltd. (SH: 600196; HK: 02196) and entities related to the company announced the acquisition of a 95.2% stake in Alma Lasers Ltd....
by Carl-Johan Skoeld | Aug 26, 2013 | China M&A, China Outbound M&A, China Private Equity, General, Healthcare, SSCO Newsletters
This post was originally published in August issue of our healthcare newsletter China Healthcare Deals+Strategies. Subscribe (email) to our newsletter to learn more about our perspectives and insights on China’s healthcare sector. Medical devices: Strategic...
